Purpose and policy objective
- BFAD Bureau Circular No. 11-A, s. 1999 requires submission to validate and update records of registered drug products active in the market.
- The circular mandates that BFAD must look at all validly registered products and those actually active in the market to pursue the activity.
Who must comply
- BFAD Bureau Circular No. 11-A, s. 1999 directs all drug manufacturers, traders, and distributors to submit the required list of products.
- The required list must be submitted by the persons/entities that have registered drug products and are involved in distribution and trading in the market.
What must be submitted
- BFAD Bureau Circular No. 11-A, s. 1999 requires submission of a list of products together with their CPR numbers.
- Submission must be made using the attached form (A, B, C).
Deadline and where to file
- BFAD Bureau Circular No. 11-A, s. 1999 requires submission not later than June 30, 1999.
- All submissions must be addressed to the Office of the Director, BFAD.
Consequences for non-submission
- BFAD Bureau Circular No. 11-A, s. 1999 provides that failure to submit the required list will prompt BFAD to review the Certificates of Product Registration.
- BFAD Bureau Circular No. 11-A, s. 1999 provides that BFAD may delete inactive products from the list of registered drug products after due notice.
Administrative compliance requirement
- BFAD Bureau Circular No. 11-A, s. 1999 states that the directive is issued for compliance.
- Compliance is measured by timely submission of the required product list with CPR numbers using the attached forms (A, B, C) by June 30, 1999.